Pfizer Expands in Cancer With $10.6 Billion Deal for Array

(Bloomberg) -- Pfizer Inc. will buy Array BioPharma Inc. for $10.6 billion to gain its promising new medicines for cancer, which could end or limit the use of punishing chemotherapy for some patien...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.